BioNTech Stock Target Price and Analyst Consensus

BNTX Stock  USD 120.88  0.28  0.23%   
The current analyst and expert consensus on BioNTech is Strong Buy with 5 hold recommendations. The current projected BioNTech target price consensus is 136.62 with 21 analyst opinions. One of the most common ways BioNTech SE analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to BioNTech vendors, executives, and/or customers. BioNTech recommendation module provides expert sentiment on the projected BioNTech SE target price to derive its highest and lowest estimates based on target price standard deviation of 3.1915.
Lowest Forecast
124.32
Highest Forecast
151.65
Target Price
136.62
Gross Profit is likely to rise to about 4.8 B in 2025. Pretax Profit Margin is likely to rise to 0.29 in 2025. At this time, BioNTech's Other Assets are fairly stable compared to the past year. Cash And Short Term Investments is likely to rise to about 20 B in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 162.4 M in 2025.
  
It's important to approach BioNTech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

BioNTech Target Price Consensus

BioNTech target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. BioNTech's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   21  Strong Buy
Most BioNTech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand BioNTech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of BioNTech SE, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

BioNTech Target Price Projection

BioNTech's current and average target prices are 120.88 and 136.62, respectively. The current price of BioNTech is the price at which BioNTech SE is currently trading. On the other hand, BioNTech's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

BioNTech Market Quote on 31st of January 2025

Low Price120.0Odds
High Price124.0Odds

120.88

Target Price

Analyst Consensus On BioNTech Target Price

Low Estimate124.32Odds
High Estimate151.65Odds

136.6187

Historical Lowest Forecast  124.32 Target Price  136.62 Highest Forecast  151.65
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on BioNTech SE and the information provided on this page.

BioNTech Analyst Ratings

BioNTech's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about BioNTech stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of BioNTech's financials, market performance, and future outlook by experienced professionals. BioNTech's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize BioNTech price targets

BioNTech's stock target price is an estimate of its future price, usually made by analysts. Using BioNTech's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at BioNTech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if BioNTech's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional BioNTech Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of BioNTech is a key component of BioNTech valuation and have some predictive power on the future returns of a BioNTech.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
117.88121.07124.26
Details
Intrinsic
Valuation
LowRealHigh
114.32117.51132.97
Details
Naive
Forecast
LowNextHigh
117.26120.45123.64
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.44-0.83-0.36
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars Idea
Driverless Cars
Invested over 300 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Momentum Idea
Momentum
Invested few shares
Banking Idea
Banking
Invested over 30 shares
FinTech Idea
FinTech
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 300 shares
Chemicals Idea
Chemicals
Invested over 30 shares

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.